FDA plan to fast-track Pfizer vaccine for kids under 5 fails to deliver, leaving parents waiting until April
Vaccination for children under 5 delayed until April as FDA and Pfizer await more data on a third dose's safety and efficacy. The delay, aimed at ensuring vaccine safety, follows insufficient immune response from two doses in trials. FDA emphasizes adherence to rigorous standards amidst urgent public health needs.
Reference News
FDA plan to fast-track Pfizer vaccine for kids under 5 fails to deliver, leaving parents waiting until April
Vaccination for children under 5 delayed until April as FDA and Pfizer await more data on a third dose's safety and efficacy. The delay, aimed at ensuring vaccine safety, follows insufficient immune response from two doses in trials. FDA emphasizes adherence to rigorous standards amidst urgent public health needs.